It considers applications involving bacteria, viruses (excluding HIV), fungi and single celled or multicellular parasites.
The List of Reviewers lists all present, whether permanent or temporary, to provide the full scope of expertise present on that date. Lists are posted 30 days before the meeting and are tentative, pending any last minute changes.
The membership panel is a list of chartered members only.
- Design and execution of clinical and field studies for testing agents or strategies for preventing or treating infectious diseases
- Clinical and field studies of strategies to control the transmission of infectious diseases
- Identification of factors involved in the pathogenesis, emergence and spread of infectious diseases in humans.
- Diagnostics for the detection, identification, and surveillance of infectious diseases
- Molecular epidemiology of infectious diseases, including genetic characterization of both the pathogen and the host
- Studies that address the potential infectious etiology of human disease
Overlaps with Closely Related Study Sections
There are shared interests with Infectious, Reproductive, Asthma and Pulmonary Conditions Study Section (IRAP) in the area of epidemiology of infectious diseases. Grant applications that focus on population-based epidemiology of infectious diseases and host characteristics, epigenetics, and behavioral, social and environmental factors may be reviewed in IRAP. Applications that focus on molecular epidemiology where the infectious agent is the focus may be reviewed in CRFS.
There are shared interests with Immunity and Host Defense Study Section (IHD) in consideration of the host response to infectious agents. Grant applications that focus on immune responses to infectious agents that include mechanisms of the host response and animal models may be reviewed in IHD. Applications that focus on population-based studies while examining immune responses to the pathogens may be reviewed in CRFS.
There are shared interests with Host Interactions with Bacterial Pathogens (HIBP) and Bacterial Pathogenesis (BACP) in advancing the knowledge of bacterial pathogenesis. Grant applications that focus on general pathogenesis issues associated with bacterial infections including host-bacterial interactions and mechanistic in vitro studies or animal models of bacterial diseases may be reviewed in HIBP or BACP. Applications that focus on epidemiology, diagnostics, emergence, spread and control of bacterial pathogens in the context of human infections may be reviewed in CRFS.
There are shared interests with Pathogenic Eukaryotes Study Section (PTHE) in the general area of eukaryotic pathogens. Grant applications focused on mechanistic in vitro studies and animal models of eukaryotic pathogens may be reviewed in PTHE. Population-based studies examining human-eukaryotic pathogen interaction, epidemiology or diagnostics of eukaryotic pathogens may be reviewed in CRFS.
There are shared interests with Virology A (VIRA) & Virology B (VIRB) in the general area of viral pathogens. Grant applications focused on mechanistic in vitro studies and animal models of viral diseases may be reviewed in VIRA or VIRB. Population-based studies examining human-virus interactions, epidemiology or diagnostics of viruses may be reviewed in CRFS.
There are shared interests with Small Business: Non-HIV Infectious Agent Detection/Diagnostics, Food Safety, Sterilization/Disinfection and Bioremediation Special Emphasis Panel (IDM (12)) in the area of infectious disease diagnostic development. R21 or R03 grant applications that seek to develop new technologies for diagnostic purposes may be reviewed in IDM (12). R01 applications addressing diagnostic development or any applications addressing diagnostics for the purpose of advancing epidemiological principles or questions related to infectious disease transmission may be reviewed in CRFS.